Odonate, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improve and extend the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Odonate Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Odonate Inc market cap is $54.85B.
What is the 52-week high for Odonate Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Odonate Inc 52 week high is $176,040.00 as of September 05, 2025.
What is the 52-week low for Odonate Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Odonate Inc 52 week low is $22,005.00 as of September 05, 2025.
What is Odonate Inc stock price today?
Odonate Inc stock price today is $50,000.00.
What was Odonate Inc stock price yesterday?
Odonate Inc stock price yesterday was $176,040.00.
What is the 50-day moving average of Odonate Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Odonate Inc 50-day moving average is $150,000.00.